Alzamend Neuro posts $3.03M quarterly net loss
For the quarter ended July 31, 2026, Alzamend Neuro reported a net loss of $3.03M and diluted net loss per share of $(0.68). The company recorded no product revenue.
Alzamend Neuro, Inc. reported a net loss of $3.03M for the quarter ended July 31, 2026, versus a net loss of $2.7M in the same quarter a year earlier. Diluted net loss per share was $(0.68), and the company said it recorded no product revenue for the period.